好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Early Neurological Deterioration in Patients with Minor Stroke due to Isolated M2 Occlusion Undergoing Medical Management: A Retrospective Multicenter Study
Cerebrovascular Disease and Interventional Neurology
P1 - Poster Session 1 (8:00 AM-9:00 AM)
5-019

Here we report a retrospective multicenter analysis on consecutive patients with minor AIS due to isolated occlusion of the M2 segment that received best medical management (BMM) only or that initially received BMM but were then subjected to rescue mechanical thrombectomy (rMT) following an early worsening of symptoms. Our primary purpose was to define predictors of clinical outcome. The secondary aim was to identify predictors of early neurological deterioration (END).

END is frequent in patients with AIS due to involvement of the M2 segment and represents the most important predictor of long-term poor outcome in such patients. In case of END, rMT represents a feasible treatment option that can improve the clinical outcome. Hence, the search of baseline features for the identification of patients that are at risk for END is relevant.

Patients with M2 occlusion and a baseline NIHSS score≤5 that received either BMM only or rMT on END after BMM were extracted from the databases of 16 comprehensive stroke centers. Clinical outcome measures were a 90-day modified Rankin Scale (mRS) score of 0-1 or 0-2, and occurrence of END.

208 patients, admitted between 2016 and 2021, were collected. END was reported in 87 patients that were therefore all subjected to rMT. In a logistic regression model, END (OR 3.386, 95% CI 1.428-8.032), baseline NIHSS score (OR 1.362, 95% CI 1.004-1.848) and a pre-event mRS score=1 (OR 3.226, 95% CI 1.229- 8.465) were associated with unfavorable outcome. In patients with END, successful rMT was associated with favorable outcome (OR 4.549, 95% CI 1.098-18.851). Among baseline features, presence of atrial fibrillation was a predictor of END (OR 3.547, 95% CI 1.014-12.406).

Patients with minor stroke due to M2 occlusion and atrial fibrillation should be closely monitored for possible worsening during BMM and, in this case, promptly considered for rMT.
Authors/Disclosures
Francesca Colò, MD (Policlinico Agostino Gemelli)
PRESENTER
Dr. Colò has nothing to disclose.
Valerio Brunetti No disclosure on file
Andrea Alexandre No disclosure on file
Iacopo Valente No disclosure on file
Giovanni Frisullo, PhD (Univ Catt S Cuore Polic Gemelli) Dr. Frisullo has nothing to disclose.
Alessandro Pedicelli No disclosure on file
Irene Scala, Jr., MD Dr. Scala has nothing to disclose.
Paolo Calabresi, MD (Clinica Neurologica) Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie, Bial, Bayer Schering, Biogen-Dompè, Biogen-Idec, Eisai, Lilly, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Sanofi-Genzyme, Teva, UCB Pharma, Zambon..
Aldobrando Broccolini No disclosure on file